|
1
|
Fidelity Investments
Boston,
Massachusetts
|
$172M
|
+$1M
|
+21,329
|
+0.7%
|
|
|
2
|
Atlas Venture Life Science Advisors
Cambridge,
Massachusetts
|
$126M
|
–
|
–
|
–
|
|
|
3
|
|
$108M
|
-$2.34M
|
-49,733
|
-2%
|
|
|
4
|
Frazier Life Sciences Management
Palo Alto,
California
|
$87.6M
|
-$4.7M
|
-100,000
|
-6%
|
|
|
5
|
RA Capital Management
Boston,
Massachusetts
|
$83.5M
|
–
|
–
|
–
|
|
|
6
|
Janus Henderson Group
London,
|
$82.3M
|
+$6.14M
|
+130,702
|
+9%
|
|
|
7
|
T. Rowe Price Associates
Baltimore,
Maryland
|
$80.3M
|
+$7.39M
|
+157,371
|
+12%
|
|
|
8
|
Wellington Management Group
Boston,
Massachusetts
|
$75.8M
|
-$42.8M
|
-911,409
|
-39%
|
|
|
9
|
|
$74.9M
|
–
|
–
|
–
|
|
|
10
|
Vanguard Group
Malvern,
Pennsylvania
|
$74M
|
+$4.31M
|
+91,690
|
+7%
|
|
|
11
|
Paradigm Biocapital Advisors
New York
|
$64.1M
|
–
|
–
|
–
|
|
|
12
|
Siren LLC
Greenwich,
Connecticut
|
$58.2M
|
+$1.29M
|
+27,536
|
+3%
|
|
|
13
|
State Street
Boston,
Massachusetts
|
$49.2M
|
+$526K
|
+11,201
|
+1%
|
|
|
14
|
Deerfield Management
New York
|
$48.7M
|
+$6.44M
|
+137,070
|
+18%
|
|
|
15
|
Woodline Partners
San Francisco,
California
|
$45.9M
|
+$17.1M
|
+364,725
|
+73%
|
|
|
16
|
|
$44.7M
|
+$3.96M
|
+84,278
|
+11%
|
|
|
17
|
Logos Global Management
San Francisco,
California
|
$37.1M
|
+$14.4M
|
+305,658
|
+78%
|
|
|
18
|
Geode Capital Management
Boston,
Massachusetts
|
$31.7M
|
+$1.25M
|
+26,605
|
+5%
|
|
|
19
|
Bain Capital Life Sciences Investors
Boston,
Massachusetts
|
$30.9M
|
-$18.8M
|
-400,000
|
-41%
|
|
|
20
|
TCG Crossover Management
Palo Alto,
California
|
$24.6M
|
–
|
–
|
–
|
|
|
21
|
Adage Capital Partners
Boston,
Massachusetts
|
$23.8M
|
+$7.05M
|
+150,000
|
+50%
|
|
|
22
|
Armistice Capital
New York
|
$23.1M
|
–
|
–
|
–
|
|
|
23
|
Saturn V Capital Management
Austin,
Texas
|
$21M
|
-$5.73M
|
-122,062
|
-24%
|
|
|
24
|
Baker Bros. Advisors
New York
|
$17.9M
|
+$12.2M
|
+260,000
|
+337%
|
|
|
25
|
Eventide Asset Management
Boston,
Massachusetts
|
$16.3M
|
+$5.93M
|
+126,212
|
+69%
|
|
